Company profile: MyMeds and Me
1.1 - Company Overview
Company description
- Provider of a web-based, configurable platform for capturing and reporting adverse events and product quality complaints across channels and languages. Solutions include public/direct website reporting, multilingual field force tools (online/offline), call centre workflows with downstream data transfer, affiliate guided collection with translation and routing, and standardized patient support program data capture.
Products and services
- Reportum: A configurable platform that captures adverse events and product quality complaints across various channels and languages for drug safety and product quality complaint reporting
- Call Centre: A workflow-driven interface featuring expert user tools and guided processes to streamline report time and ensure data transfer to downstream systems
- Public / Direct Reporting: A web-based module enabling direct reporting of safety data through corporate and product websites, capturing adverse events and product complaints directly via those sites
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to MyMeds and Me
GenoLogics
HQ: Canada
Website
- Description: Provider of discovery and biomedical solutions and collaborative data management software for life sciences research, deployable across multiple labs to support translational medicine and systems biology, advancing early detection, prevention, and treatment of disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GenoLogics company profile →
StudyKIK
HQ: United States
Website
- Description: Provider of patient recruitment and retention technology for clinical trials, connecting trial companies with volunteers and offering KIKsite for data management and communication, Virtual Visits, CarePackage integrating telemedicine and eConsent, PatientEngage+ for enrollment and engagement, and SupportHub for outreach, appointment reminders, and transportation coordination.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full StudyKIK company profile →
NTx
HQ: United States
Website
- Description: Provider of a proprietary host-independent biological manufacturing and development platform.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NTx company profile →
Context Matters
HQ: United States
Website
- Description: Provider of a next-generation data platform linking drug development and market data, helping pharmaceutical companies access and understand complex data. Offers Cortellis Regulatory Intelligence covering global health authority requirements for human healthcare products (drugs, biologics, medical devices, IVDs) and Cortellis CMC Intelligence for CMC documentation, reducing regulatory delays and rejections.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Context Matters company profile →
Intomics
HQ: Denmark
Website
- Description: Provider of core biological insights from analysis and integration of biomedical big data, leveraging bioinformatics and systems biology to accelerate and improve drug discovery and development through optimized usage of biomedical data.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Intomics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for MyMeds and Me
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to MyMeds and Me
2.2 - Growth funds investing in similar companies to MyMeds and Me
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for MyMeds and Me
4.2 - Public trading comparable groups for MyMeds and Me
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →